News Clip5:05
The Recount

How To Talk To Your Vax-Skeptic Uncle

Higher Ed
The holidays are a time for warm family gatherings… and sometimes, heated conversations. With the Omicron variant threatening to disrupt another season, arguing about the coronavirus vaccine is on the table. We talk with two medical...
News Clip5:07
Bloomberg

Pfizer Vaccine Provides Less Immunity to Omicron Variant

Higher Ed
Pfizer Inc.'s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain. Bloomberg...
News Clip2:21
Bloomberg

Vaccines May Not Prevent Covid From Becoming Endemic: Heymann

Higher Ed
Sep.29 -- London School of Hygiene & Tropical Medicine Professor David Heymann examines expectations for a coronavirus vaccine and concerns about protecting the world’s older population. He speaks on "Bloomberg Markets: European Close."
News Clip7:57
Bloomberg

WHO Advisor on Omicron's Spread & Government Measures

Higher Ed
University of New South Wales and WHO Advisor Mary-Louise McLaws discusses measures being taken by governments as Covid cases soar globally. She speaks in "Bloomberg Daybreak Australia" with Haidi Stroud-Watts.
News Clip3:25
Curated Video

Scientists make progress in search for vaccine

Higher Ed
1. Pan exterior of Robert Koch Institute 2. Medium shot Robert Koch Institute 3. Reinhard Kurt, Frans van den Boom and Jan van Lunzen entering 4. Auditorium 5. SOUNDBITE (German) Jan van Lunzen, University Hospital of Hamburg...
News Clip9:46
Curated Video

ROVING REPORT: RR0111/A KENYA: AIDS

Higher Ed
AIDS has become the scourge of Africa less than 20 years after being identified. Acquired Immune Deficiency Syndrome hit Africans first and hardest. But one of the countries worst affected, Kenya, has provided what could be a...
News Clip2:50
Curated Video

Who Isn't Getting COVID?

Higher Ed
Earlier this year, the CDC estimated that 43% of Americans have had COVID.
News Clip7:05
Bloomberg

The Cancer Advance Causing CK Life Sciences’s Stock to Surge

Higher Ed
Nov.07 -- Alan Yu, vice president and chief operating officer at CK Life Sciences, discusses the drug advance that’s causing its share price to surge, where he is in the approval process, when the drug will be available to the public,...
News Clip6:32
Bloomberg

How the Coronavirus Hijacks Your Cells

Higher Ed
Apr.29 -- The virus that causes Covid-19 is so tiny that it can only be viewed through an electron microscope. Scientists have been studying what the virus does to our cells. Here’s what they've discovered so far. (Video by Vicky Feng)
News Clip7:16
Bloomberg

Bloomberg Intelligence on the Frontiers of Cancer Research

Higher Ed
Oct.13 -- Bloomberg Intelligence’s Sam Fazeli explained what could potentially revolutionize cancer therapy over the next 10 years.
News Clip48:43
Press Association

Coronavirus press briefing in full: January 4 2022

Higher Ed
Boris Johnson, Sir Chris Whitty and Sir Patrick Vallance press conference from January 4 2022 in full. Boris Johnson says there is a “good chance” he will not have to impose fresh restrictions to tackle the massive wave of Omicron cases,...
News Clip3:24
Press Association

Smoking quit rate in 2020 ‘highest in more than a decade’

Higher Ed
Interview with Scott Crosby, tobacco control programme manager at Public Health England. The proportion of people who have successfully quit smoking this year is at its highest in more than a decade, new figures show. Data from the UCL...
News Clip4:54
Bloomberg

As U.S. Virus Cases Surge, Will Death Rates Rise Too?

Higher Ed
Jun.26 -- After the U.S. registered the biggest-ever jump in coronavirus cases, is it just a matter of time before death rates also start to increase? Bloomberg's John Lauerman reports on the surge in infections and breaks down the...
News Clip11:20
Bloomberg

Roche to Launch Virus Antibody Test at Start of May: CEO

Higher Ed
Apr.22 -- Severin Schwan, chief executive officer at Roche Holding AG, discusses the company’s antibody tests to help fight coronavirus and what sets his tests apart from others in the industry. He speaks on “Bloomberg Markets: European...
News Clip2:02
AFP News Agency

CLEAN : Felipe future king of Spain has many challenges ahead (expert)

9th - Higher Ed
CLEAN : Felipe future king of Spain has many challenges ahead (expert)
News Clip3:23
AFP News Agency

CLEAN : Home based Medications for People under Ebola Quarantine

9th - Higher Ed
CLEAN : Home based Medications for People under Ebola Quarantine
News Clip2:38
Curated Video

When Will Kids Have A Covid-19 Vaccine?

Higher Ed
Drug makers are predicting children could be vaccinated before the beginning of the school year but some experts say that's overly optimistic.
News Clip2:16
Bloomberg

Tiziana Life Sciences Chairman on New Covid Drug

Higher Ed
Mar.30 -- Tiziana Life Sciences Chairman Gabriele Cerrone discusses new covid-19 drug announcements. He speaks with Amanda lang on "Bloomberg Markets."
News Clip4:50
Bloomberg

Booster Shot Is Needed, Says Tiziana Life Sciences' Weiner

Higher Ed
Sep.02 -- Howard Weiner Harvard Medical School Professer and Tiziana Life Sciences Chief Scientific Officer, says we ultimately need a 3rd vaccine about 6-8 months after the first dose. He speaks with Guy Johnson and Alix Steel on...
News Clip3:54
Bloomberg

Vaccine Development Process Can Be Safely Accelerated: Johns Hopkins

Higher Ed
Oct.15 -- Johns Hopkins International Vaccine Access Center Executive Director William Moss discusses ways to safely accelerate the coronavirus vaccine development process, challenges in delivering a vaccine to patients, and the...
News Clip5:14
Curated Video

Platelet and blood donations are vital to the survival of premature babies ++EMBARGOED++

Higher Ed
Liverpool, United Kingdom, 26th November 2008 1. Mid shot of twins Imogen (nearest to camera) and Isobel (furthest from camera) in play pen with mother Louisa 2. Wide top view of mum Louisa and twins in play pen 3. Close up Isobel 4....
News Clip5:00
AFP News Agency

CLEAN : US: The supercells that cured an infant's grave genetic illness

9th - Higher Ed
When Johan was born with a grave genetic illness called chronic granulomatous disease he benefited from a still experimental type of treatment known as T-cell therapy that helped his immune system fight off viruses after he received a...
News Clip6:02
Bloomberg

Moderna Chair Says Covid Pandemic May Shift to Endemic in 2022

Higher Ed
Moderna Inc. co-founder Noubar Afeyan says the Covid-19 pandemic could start moving into an endemic phase in 2022. "It really depends on what happens and the decisions that are made across the world," Afeyan said on Bloomberg Television,...
News Clip3:15
Press Association

Brazilian variant 'worrying', says infectious diseases expert

Higher Ed
Interview with Lawrence Young, an expert in infectious diseases at Warwick University, on concerns of a Brazilian coronavirus variant. UK ministers have banned the arrival of travellers from South America to limit the spread of a new...